Thermo Fisher Scientific/$TMO
13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX
About Thermo Fisher Scientific
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
Ticker
$TMO
Sector
Primary listing
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
125,000
ISIN
US8835561023
Website
TMO Metrics
BasicAdvanced
$148B
23.02
$17.06
0.83
$1.60
0.44%
Price and volume
Market cap
$148B
Beta
0.83
52-week high
$622.30
52-week low
$385.46
Average daily volume
2.7M
Dividend rate
$1.60
Financial strength
Current ratio
1.775
Quick ratio
1.093
Long term debt to equity
63.393
Total debt to equity
69.231
Dividend payout ratio (TTM)
9.16%
Interest coverage (TTM)
5.90%
Profitability
EBITDA (TTM)
10,826
Gross margin (TTM)
41.37%
Net profit margin (TTM)
15.18%
Operating margin (TTM)
18.30%
Effective tax rate (TTM)
6.74%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
5.00%
Return on equity (TTM)
13.70%
Valuation
Price to earnings (TTM)
23.017
Price to revenue (TTM)
3.487
Price to book
3.01
Price to tangible book (TTM)
-11.93
Price to free cash flow (TTM)
22.244
Free cash flow yield (TTM)
4.50%
Free cash flow per share (TTM)
1,764.83%
Dividend yield (TTM)
0.41%
Forward dividend yield
0.44%
Growth
Revenue change (TTM)
0.96%
Earnings per share change (TTM)
9.37%
3-year revenue growth (CAGR)
1.42%
10-year revenue growth (CAGR)
9.76%
3-year earnings per share growth (CAGR)
-3.85%
10-year earnings per share growth (CAGR)
14.75%
3-year dividend per share growth (CAGR)
14.00%
10-year dividend per share growth (CAGR)
10.31%
What the Analysts think about TMO
Analyst ratings (Buy, Hold, Sell) for Thermo Fisher Scientific stock.
Bulls say / Bears say
Thermo Fisher Scientific reported adjusted earnings per share of $5.15 for Q1 2025, surpassing analyst expectations of $5.10, indicating strong financial performance. (tradingview.com)
The company announced a $2 billion investment in U.S. manufacturing and R&D over the next four years, aiming to enhance operations and drive innovation. (finviz.com)
Thermo Fisher's acquisition of 3M's former filtration and purification business for $4.1 billion is expected to broaden its product line and strengthen its position in the biopharmaceutical sector. (bostonglobe.com)
Thermo Fisher's stock declined by 5.5% after cutting its profit outlook due to a growth slump in China and slowing demand from drug makers. (bloomberglaw.com)
Wells Fargo & Company reduced its price target for Thermo Fisher Scientific to $570, reflecting concerns over the company's future performance. (etfdailynews.com)
The company announced the closure of its Orlando location and layoffs of 58 employees, indicating potential operational challenges. (finviz.com)
Data summarised monthly by Lightyear AI. Last updated on 22 May 2025.
TMO Financial Performance
Revenues and expenses
TMO Earnings Performance
Company profitability
TMO News
AllArticlesVideos
Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss, Femtonics, Hitachi, Thermo Fisher Scientific and More
GlobeNewsWire·6 hours ago
Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions
Business Wire·4 days ago
Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business
PYMNTS·7 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul15
Thermo Fisher Scientific
Dividend·Payment
$0.43Per share
FAQs
What’s the current market cap for Thermo Fisher Scientific stock?
Thermo Fisher Scientific (TMO) has a market cap of $148B as of June 20, 2025.
What is the P/E ratio for Thermo Fisher Scientific stock?
The price to earnings (P/E) ratio for Thermo Fisher Scientific (TMO) stock is 23.02 as of June 20, 2025.
Does Thermo Fisher Scientific stock pay dividends?
Yes, the Thermo Fisher Scientific (TMO) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is $1.6 and the yield is 0.44%. Thermo Fisher Scientific has a payout ratio of 9.16% on a trailing twelve-month basis.
When is the next Thermo Fisher Scientific dividend payment date?
The next Thermo Fisher Scientific (TMO) dividend payment is scheduled for July 15, 2025.
What is the beta indicator for Thermo Fisher Scientific?
Thermo Fisher Scientific (TMO) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.